L
Liquidia Technologies
Development and commercialization of human therapeutics
About Liquidia Technologies
Liquidia Technologies is a late-stage clinical biopharmaceutical company specializing in the development and commercialization of therapeutics using its proprietary PRINT technology. This technology allows for the precise engineering of drug particles, which aims to improve the safety, efficacy, and performance of a wide range of therapies while reducing manufacturing complexity and cost. Liquidia is currently focused on two primary product candidates: LIQ861, designed for the treatment of pulmonary arterial hypertension, and LIQ865, aimed at managing local post-operative pain. The company operates in the biopharmaceutical market, primarily serving patients with specific medical conditions that require advanced therapeutic solutions. Liquidia's business model revolves around the development, clinical testing, and eventual commercialization of its drug candidates. Revenue is generated through the sale of these therapeutics once they receive regulatory approval and are brought to market. The company also engages in public offerings of common stock to fund its operations and research initiatives.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2018
News
Open roles
Liquidia Technologies in the Morrisville ecosystem
The Liquidia Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Wakefield Group LLC- FMFirelake Capital Management
N47
NEA
Jenny Rooke
Series B and later4 investors entered at this stage
Canaan
Standard Treasury
HealthCare Royalty
Caligan Partners
Source: Dealroom Talent Intelligence.
Patents
9 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Liquidia Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

